{
  "resourceType" : "CodeSystem",
  "id" : "v3-hc-aigc",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem v3-hc-aigc</b></p><a name=\"v3-hc-aigc\"> </a><a name=\"hcv3-hc-aigc\"> </a><a name=\"v3-hc-aigc-en-US\"> </a><p>This case-insensitive code system <code>http://terminology.hl7.org/CodeSystem/v3-hc-aigc</code> defines codes, but no codes are represented here</p></div>"
  },
  "url" : "http://terminology.hl7.org/CodeSystem/v3-hc-aigc",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.5.1104"
  }],
  "version" : "3.0.1",
  "name" : "HcAIGC",
  "title" : "Active Ingredient Group Code",
  "status" : "active",
  "experimental" : false,
  "date" : "2021-03-22T00:00:00-04:00",
  "publisher" : "Health Canada",
  "contact" : [{
    "name" : "Health Canada"
  }],
  "description" : "Part of the active ingredient code number starting at position 3 and ending at position 7.  \r\n\r\nFurther information about this Code System can be found at https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/terminology.html",
  "caseSensitive" : false,
  "content" : "not-present"
}